Document Detail

The temporal course of intracranial haemorrhage progression: How long is observation necessary?
MedLine Citation:
PMID:  22658418     Owner:  NLM     Status:  Publisher    
INTRODUCTION: Patients with mild traumatic brain injury (MTBI) and intracranial haemorrhage (ICH) are hospitalized and monitored for progression of injury. The timeframe for ICH progression is unknown, and so the optimal duration and location of observation are generally discretionary. The goal of this study was to examine the temporal course of injury progression and establish a timeframe for when haemorrhage ceases. METHODS: We performed a retrospective review of all adult patients (age≥18) with MTBI (GCS≥13) and ICH admitted to a level 1 trauma centre over a consecutive 36 month period, who underwent a minimum of 2 cranial CT scans (HCT) within 48h from ED presentation prior to any neurosurgical intervention (NSI). Patients with a history of NSI or nontraumatic cerebral lesions were excluded. Data collected include demographics and the number, timing and findings of serial HCT scans. RESULTS: A total of 341 patients met inclusion criteria. The timing for cessation of bleeding could not be confirmed in 37 patients (11 had NSI after 2nd HCT, 1 died of coagulopathy prior to NSI and 25 had no repeat HCT that could confirm the cessation of bleeding). Of the remaining 304 ICH, 96% stopped progressing by 24h and 99% by 48h. The remaining 1% stopped by 72h. Of all 341 ICH, 236 (69%) showed no progression after initial HCT, indicating that haemorrhage had stopped by that time (1.2h (SD±1.1h) from admission). None required a NSI. CONCLUSION: Almost all ICH in MTBI stop progressing within the first 24h post injury, supporting a 24-h observational period. In fact, over 3/4s of ICH has stopped by the time of the initial HCT (<2h from arrival). This suggests that early repeat HCT may identify those ICH no longer progressing, and possibly avoid unnecessary admission and prolonged observation in those patients not requiring admission for post-TBI symptom management. Prospective data are needed to evaluate this proposed paradigm change in the management of MTBI.
Adena Homnick; Ziad Sifri; Peter Yonclas; Alicia Mohr; David Livingston
Related Documents :
12635898 - Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of ...
9146568 - Terbinafine therapy may be associated with the development of psoriasis de novo or its ...
11476108 - Lipid analysis of peripheral blood monocytes in psoriatic patients using fourier-transf...
22072348 - Biochemical and functional indices of malnutrition in patients with operable, non-micro...
19426588 - Dual extradural cortical stimulation in chronic stroke patients with large infarcts: te...
23839228 - Virtual chromoendoscopy for prediction of severity and disease extent in patients with ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-31
Journal Detail:
Title:  Injury     Volume:  -     ISSN:  1879-0267     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-6-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0226040     Medline TA:  Injury     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
UMDNJ-NJMS (New Jersey Medical School), United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Injuries associated with serious brachial plexus involvement in polytrauma among patients requiring ...
Next Document:  Perioperative glucocorticosteroid treatment delays early healing of a mandible wound by inhibiting o...